321 results on '"Cordeiro, Yraima"'
Search Results
2. Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease
3. (Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation
4. New mescaline-related N-acylhydrazone and its unsubstituted benzoyl derivative: Promising metallophores for copper-associated deleterious effects relief in Alzheimer's disease
5. In Vitro Characterization of Protein:Nucleic Acid Liquid–Liquid Phase Separation by Microscopy Methods and Nanoparticle Tracking Analysis
6. Novel Method for the Production, Purification, and Characterization of Recombinant Lunasin: Identification of Disulfide Cross-Linked Dimers
7. Phase Separation and Disorder-to-Order Transition of Human Brain Expressed X-Linked 3 (hBEX3) in the Presence of Small Fragments of tRNA
8. Modulation of p53 and prion protein aggregation by RNA
9. Intrinsic disorder and phase transitions: Pieces in the puzzling role of the prion protein in health and disease
10. Copper drives prion protein phase separation and modulates aggregation
11. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases
12. PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma
13. Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice
14. RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction
15. Conformational dissection of Thermomyces lanuginosus lipase in solution
16. How oxidized EGCG remodels α-synuclein fibrils into non-toxic aggregates: insights from computational simulations.
17. Targeting Biomolecular Condensation and Protein Aggregation against Cancer.
18. Phase separation of the mammalian prion protein: Physiological and pathological perspectives.
19. Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus
20. Pressure–temperature folding landscape in proteins involved in neurodegenerative diseases and cancer
21. Nucleic acid actions on abnormal protein aggregation, phase transitions and phase separation
22. Phase separation of the mammalian prion protein: Physiological and pathological perspectives
23. Prion protein complexed to a DNA aptamer induce behavioral and synapse dysfunction in mice
24. Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids
25. Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases
26. Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
27. Structural basis for the dissociation of α-synuclein fibrils triggered by pressure perturbation of the hydrophobic core
28. Effects of compressed fluids on the activity and structure of horseradish peroxidase
29. Enhanced prion protein stability coupled to DNA recognition and milieu acidification
30. Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
31. Allosteric function and dysfunction of the prion protein
32. Recognition mechanism of d- and l-tryptophan enantiomers using 2-hydroxypropyl-α- or β-cyclodextrins as chiral selectors
33. Rabbit PrP Is Partially Resistant to in vitro Aggregation Induced by Different Biological Cofactors
34. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
35. Intriguing nucleic-acid-binding features of mammalian prion protein
36. The interplay between a GC-rich oligonucleotide and copper ions on prion protein conformational and phase transitions
37. Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
38. Accommodation of In-Register N-Linked Glycans on Prion Protein Amyloid Cores
39. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies
40. Liquid‐liquid phase separation and fibrillation of the prion protein modulated by a high‐affinity DNA aptamer
41. Synthesis and in silico and in vitro evaluation of trimethoxy-benzamides designed as anti-prion derivatives
42. Liquid-liquid phase separation and aggregation of the prion protein globular domain modulated by a high-affinity DNA aptamer
43. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells
44. Diosmin induces caspase-dependent apoptosis in human glioblastoma cells
45. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant
46. Liquid‐liquid phase separation and fibrillation of the prion protein modulated by a high‐affinity DNA aptamer.
47. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.
48. Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins
49. Structural insights into the interaction between prion protein and nucleic acid
50. Publish and perish in the hands of predatory journals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.